title: [Drug-induced renal disorders in patients with rheumatoid arthritis].
authors.forename: M
authors.initials: M
authors.lastname: Nakano
authors.forename: S
authors.initials: S
authors.lastname: Nishi
authors.forename: M
authors.initials: M
authors.lastname: Ueno
authors.forename: T
authors.initials: T
authors.lastname: Saito
authors.forename: H
authors.initials: H
authors.lastname: Hasegawa
authors.forename: M
authors.initials: M
authors.lastname: Arakawa
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D016572:Cyclosporine / Q000009:adverse effects; D003545:Cysteine / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008727:Methotrexate / Q000009:adverse effects; D062367:ortho-Aminobenzoates / Q000009:adverse effects
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D062367:ortho-Aminobenzoates; D016572:Cyclosporine; C015735:lobenzarit; D003545:Cysteine; C026535:bucillamine; D008727:Methotrexate